Chromatin regulation and organization are essential processes that regulate gene activity. The CCCTC-binding factor (CTCF) is a protein with different and important molecular functions related with chromatin dynamics. It is conserved since invertebrates to vertebrates, posing it as a factor with an important role in the physiology. In this work, we aimed to understand the distribution and functional relevance of CTCF during the embryonic development of the zebrafish (Danio rerio). We generated a zebrafish specific anti-Ctcf antibody, and found this protein to be ubiquitous, through different stages and tissues. We used the CRISPR-Cas9 system to induce molecular alterations in the locus. This resulted in early lethality. We delayed the lethality performing knockdown morpholino experiments, and found an aberrant embryo morphology involving malformations in structures through all the length of the embryo. These phenotypes were rescued with human CTCF mRNA injections, showing the specificity of the morpholinos and a partial functional conservation between the fish and the human proteins. Lastly, we found that the pro-apoptotic genes p53 and bbc3/PUMA are deregulated in the ctcf morpholino-injected embryos. In conclusion, CTCF is a ubiquitous factor during the zebrafish development, which regulates the correct formation of different structures of the embryo, and its deregulation impacts on essential cell survival genes. Overall, this work provides a basis to look for the particular functions of CTCF in the different developing tissues and organs of the zebrafish.
Introduction
Accurate regulation of the gene expression is essential for cell differentiation and organism development. This is a highly refined event that requires multiple layers of control and the contribution of a large set of components. In addition to tissue-specific and ubiquitous transcription factors, chromatin structure and the three-dimensional configuration of the genome inside the nucleus are key components for coordination and precise gene expression (García-González et al., 2016; Stricker et al., 2017) . One protein that has been shown to be part of this coordination in the nucleus is the CCCTC-binding factor (CTCF), acting in the interphase between gene regulation and chromatin organization. CTCF has a large set of functions with different mechanisms of action. It has an 11 zinc-finger central domain, and was initially described as a transcription factor with positive and negative influence on gene expression (Phillips and Corces, 2009; Arzate-Mejía et al., 2018) . A role in chromatin insulation has also been attributed to CTCF, delimitating open and close chromatin transition sites (González-Buendía et al., 2015; Ghirlando and Felsenfeld, 2016) . In recent years, CTCF has been found interacting in vivo with 30 to 70 thousand sites in mammalian genomes, depending on the cell-type (Arzate-Mejía et al., 2018) . CTCF predominantly associates with intergenic regions and introns, and to a lesser extent with proximal promoter regions and exons. Interestingly, intergenic and intronic locations of CTCF are coincident with regulatory elements, like enhancers, while in promoter regions and exons, it could be involved in alternative splicing (Ruiz-Velasco et al., 2017) . Further studies revealed the involvement of CTCF with the three-dimensional organization of the genome through chromatin loop formation (Merkenschlager and Nora, 2016) . Therefore, CTCF and its relation with chromatin illustrate how a nuclear factor can participate and coordinate different genetic and epigenetic regulatory pathways.
The phylogenetic studies suggest an early origin of CTCF in the evolution of metazoans (Heger et al., 2012) . Despite such evolutionary distribution, CTCF is absent in the nematode C. elegans and no homologs have been identified in fungi or plants (Heger et al., 2009 (Heger et al., , 2012 .
In contrast, CTCF shows a high conservation in the aminoacid sequence in the zebrafish compared to the mouse and the human protein (Pugacheva et al., 2006) . This supports a functional conservation throughout vertebrate evolution. In a previous work, Pugacheva and collaborators cloned and isolated the ctcf cDNA from zebrafish, and determined the ctcf gene expression patterns during early development (Pugacheva et al., 2006) . By whole-mount in situ hybridization, they showed that the ctcf transcript is present from the one-cell stage throughout 48 hour post-fertilization (hpf). The ctcf transcript distribution is ubiquitous until 24 hpf. From this stage on, the ctcf expression is prominent in the eye and the brain, with a strong signal in the forebrain, midbrain and hindbrain. In addition, ctcf is expressed in the notochord and the axial vessel, what we also could prove in a previous work (Pugacheva et al., 2006; Delgado-Olguín et al., 2011) . At 48 hpf, ctcf expression is modified, as it is reduced to the gut and the branchial arches. In summary, the ctcf transcript is present in all stages of the zebrafish development, localized in every cell in the early embryonic stages (< 24 hpf), and gradually changes to a more spatially restricted distribution.
It is worth to note that there is an increasing amount of data for CTCF at the molecular level, but much less is known about its role during embryonic development and homeostasis. In the zebrafish, CTCF is known to be a regulator of several genes during embryonic stages (Meier et al., 2018; Rhodes et al., 2010) , some of which has been proved to be important during the embryonic muscle development (Delgado-Olguín et al., 2011) . In the present work, we aimed to detail the influence of CTCF in the early development of the zebrafish in vivo. We generated a specific antibody against the zebrafish CTCF, and performed whole-mount immunostaining assays. Both, a temporal and spatial generalized distribution of CTCF throughout the zebrafish development were found. We performed ctcf knockout experiments using the CRISPR-Cas9 genome editing methodology showing elevated early embryo lethality. To look for CTCF functions in these stages, we Fig. 1 . Distribution of the CTCF protein through development. Whole-mount immunoflourescence staining of zebrafish embryos, from the 1-cell to the prim-16 stages (staging according to Kimmel et al., 1995) , encompassing the first 30 h of development. F. Carmona-Aldana et al. Mechanisms of Development 154 (2018) 51-59 delayed the embryo lethality with knockdown experiments, injecting embryos with ctcf morpholinos. The knockdown embryos showed a range of phenotypes affecting all the length of the body pattern. A partial rescue of the phenotype was achieved with the human CTCF transcript. We finally found that the expression of some pro-apoptotic genes (p53 and bbc3/PUMA) depend on CTCF. Together, these results demonstrated the relevance of CTCF in vivo, its central role in many different cellular pathways that, when absent, it generates severe phenotypes in the zebrafish.
Results

CTCF is ubiquitously distributed during the zebrafish development
To study the distribution of the CTCF protein during development we generated a zebrafish CTCF specific antibody (Fig. S1 ). The CTCF protein has a high identity between species in its 11 zinc-finger region, but its N-and C-terminal domains are highly divergent (Pugacheva et al., 2006) . Therefore, we expressed a portion of the C-terminal domain (aminoacids 723-798) in a bacterial system, and used it to immunize rabbits ( Fig. S1A ). We compared the antiserum specificity by Western-blot ( Fig. S1B ). We found a band of 120 kDa that is not present in the pre-immune serum, and disappears in the knockdown (morpholino injected) embryos. Also, in immunostaining assays ( Fig. S1C ), we found that the purified polyclonal antibody generates a ubiquitous signal, that is not generated with the pre-immune serum or the secondary antibody. Furthermore, we found the CTCF signal in the cell nuclei, as expected ( Fig. S1C″ ). Taking advantage of the affinity-purified anti-Ctcf antibody, we were able to perform a series of immunofluorescence staining assays during the early stages of the zebrafish development. We found a ubiquitous distribution of the CTCF protein, both, temporarily and spatially ( Fig. 1) . We detected the CTCF signal as early as the 1-cell stage, and found it virtually in every nucleus during embryonic development. The signal intensity is apparently uniform between nuclei in different regions of the embryo. Thus, the distribution of the protein is consistent with the expression pattern of the transcript, revealed by in situ hybridization (Pugacheva et al., 2006) . Overall, the CTCF protein shows a widespread uniform distribution during the zebrafish embryo development, with a nuclear localization.
CTCF knockout using the CRISPR-Cas9 genome editing system reveals an essential role during early embryogenesis
To study the effects of losing CTCF, we decided to generate knockout alleles in the zebrafish using the CRISPR-Cas9 genome editing system. After a detailed analysis of the ctcf genomic organization, we designed a single guide RNA (sgRNA) to target the 5′ portion of the first coding exon, just downstream of the translation start site ( Fig. 2A) . The sgRNA was co-injected with the in vitro transcribed Cas9 mRNA into 1cell embryos. At 24 hour post fertilization (hpf), we found lethality in 91% of the CRISPR-Cas9 injected embryos in comparison to 52% in control uninjected embryos and 35% in control Cas9 (without the sgRNA) injected embryos. We performed new injections and analyzed the embryos through development, and identified morphological changes as early as the bud stage ( Fig. 2C , staging according to Kimmel et al., 1995) . The head lacks its bulb shape, forming a "squashed" extension instead in the CRISPR-Cas9 injected embryos ("a" in Fig. 2C ). Something similar occurs with the distal portion of the tail, which is normally formed by a bulgy accumulation of tissue that ends in a fine tip. In the CRISPR-Cas9 injected embryos, the tail forms in a squashed pattern that does not end in a fine tip ("b" in Fig. 2C ). Together, these results show that the injection of the CRISPR-Cas system disrupts the embryonic development of the zebrafish.
To define what kind of molecular changes were present in the ctcf locus, we analyzed the CRISPR-Cas9 injected embryos by sequencing. We amplified the sgRNA targeted region from a pool of CRISPR-Cas9 injected embryos and performed a T7 endonuclease I assay ( Fig. S2B ). We found digested bands only in the CRISPR-Cas9 injected embryos, compared to controls. Then, we performed new PCR reactions and sequenced 13 different clones. We found indels in 6 of them (6/ 13 = 46%), with different deletions and one insertion ( Fig. 2A ). Three of these indels (Δ67 bp, Δ214 bp and Δ232 bp), have the translation start site deleted. One deletion was found twice (Δ2 bp) and generates a frameshift mutation that would correspond to changes in the protein sequence from the 8th aminoacid onwards. The insertion (+22 bp) was located just downstream of the translation start site. Thus, all these alleles are deleterious, and demonstrate the alteration of the ctcf locus in the CRISPR-Cas9 injected embryos.
CTCF knockdown experiments show severe morphological defects during development
To corroborate the phenotypes observed, we generated knockdown experiments by injecting morpholino oligonucleotides (mo) in one-cell to two-cell stage embryos. Our morpholinos were designed and validated in a previous work from our group (Delgado-Olguín et al., 2011) . We used two different morpholino sequences: One against the ctcf mRNA translation start site (mo-aug), and another targeting the splice site at the end of the first coding exon and the following intron (mo-sp). The effect of the mo-sp on the ctcf transcript splicing was validated by RT-PCR (Fig. 3A) . The efficiency of the morpholinos on the CTCF protein depletion was verified by Western-blot ( Fig. 3B ). We found that the mo-aug morphant showed a more effective CTCF reduction in comparison with the mo-sp. With either morpholino the same phenotype was found, but the mo-aug showed higher proportion of embryos with the phenotype compared to vehicle-injected embryos (Fig. 4) . Therefore, we continued working with the mo-aug injected embryos. We found a range of mild to severe phenotypes, involving all the length of the body pattern of the embryo, as checked at 24 hpf (Figs. 4 and S3 and Supplementary Table 2 ). Representative morphant phenotypes range from almost a normal aspect to a severe one. We observed morphological differences involving both, the anterior and posterior regions of the embryo, with a reduction in the body length. The head is shorter, with no segmentation between the different regions that are formed normally (the forebrain, midbrain and hindbrain), nor well developed eyes. The tail is shorter, with a lack of the notochord and the somites, in accordance with our previous results (Delgado-Olguín et al., 2011) . In embryos with a more severe phenotype, the somites are totally lost. Dark regions are evident throughout all the body, indicating dead tissue ( Fig. 4 ). Together, these results suggest a central role of CTCF in different processes during the zebrafish development.
Human CTCF mRNA rescued the CTCF morphant phenotype
To validate the specificity of our morpholino, we performed a rescue assay using the human CTCF mRNA (Fig. 5 ). In vitro transcribed human CTCF mRNA was injected with the mo-aug, at two different concentrations, and the phenotype was compared to embryos injected only with the mo-aug. As shown in Figs. 5, 50 pg of the CTCF mRNA partially rescued the morphant phenotype, as checked at 24 hpf mRNA (see also Fig. S4 and Supplementary Table 3 ). Further, a stronger rescue is achieved injecting 100 pg of the CTCF mRNA. The percentage of dead embryos at 24 hpf was reduced in the CTCF mRNA co-injected embryos. This resulted in a subtly increased percentage of embryos that survived, but that showed the morphant phenotype ( Fig. 5 and Supplementary  Table 3 ). But the phenotype in the CTCF mRNA co-injected embryos is notably less severe compared to embryos injected only with the mo-aug ( Fig. S4 ). Taken together, with these results we conclude that the coinjection of the mo-aug and the human CTCF mRNA partially rescued the morphant phenotype, validating the specificity of our morpholino oligonucleotide.
CTCF loss-of-function affects the expression of DNA damage response genes
CTCF has been previously shown to be involved in the regulation of genes related to the DNA damage response (Gomes and Espinosa, 2010; Soto-Reyes and Recillas-Targa, 2010; Saldaña-Meyer et al., 2014) . It is well known that p53 and PUMA (also known as bbc3), among others, are genes involved in cell-cycle arrest control and apoptosis (Matt and Hofmann, 2016) . We tested if the expression of these genes is deregulated in the CTCF morphants. We isolated total RNA from 12 hpf morpholino-injected and vehicle injected control embryos and performed an RT-qPCR assay. We found that the p53 and bbc3/PUMA genes are upregulated in vivo in the absence of CTCF (Fig. 6) . To further detail, we classified the morphants according to if they showed the phenotype, or if they looked wild type (Fig. 6 ). We found that the up-regulation of p53 and bbc3/PUMA occurs specifically in the morphants with an evident phenotype, while these genes are down-regulated in the morphants that looked wildtype. These results suggest that the deregulation of the p53dependent apoptosis pathway can contribute, in part, to the morphological alterations observed in the CTCF-deficient zebrafish embryos.
Discussion
CTCF is an essential factor that controls the expression of key developmental genes in different processes, like neurogenesis, limb development and myogenesis in different species (Herold et al., 2012; Arzate-Mejía et al., 2018) . Our data indicates that temporal-spatial distribution of this protein in multiple tissues in the zebrafish embryo supports a role for CTCF as a ubiquitous factor with an essential function in development.
With our data, we show for the first time, as far as we know, the distribution during development of a whole organism of this well studied factor at the protein level. The CTCF protein distribution indicates that it is virtually present in every zebrafish cell lineage, since the very early 1-cell embryo throughout 24 hpf without showing any preferential enrichment. In disagreement with the specific enrichment of the ctcf transcript expressed in the brain, the gut and the eye of the zebrafish embryo (Delgado-Olguín et al., 2011; Pugacheva et al., 2006) , we did not observe a differential accumulation of the protein in specific locations during the stages we tested (Fig. 1) . Our data show that both, the knockout and the knockdown of CTCF results in early lethality in the zebrafish (Figs. 2 and 4 ). We were able to link together the lethality, which has been also observed by other group (Meier et al., 2018; Rhodes et al., 2010) , with the distribution of the protein throughout the body axis of the embryo (Fig. 1) , and its functional relevance for morphology in different regions of the embryo (Figs. 2 and 4) . Interestingly, at 24 hpf we found lethality in the CRISPR-Cas9 injected embryos. But at that time point, an important proportion of the morphants survive, with a remarkable effect on the embryo morphology. The difference between the knockout and the knockdown of CTCF can be explained by the dilution of the morpholino molecules through the increased number of cells as the development proceeds, which would reduce the morpholino effect in later time points. In contrast, in the CRISPR-Cas9 injected embryos, we expect the mutation to be passed through cell generations. This would have as a consequence a sustained lack of CTCF during all developmental stages. A differential penetrance in lethality in CTCF-deficient zebrafish embryos has been observed previously by other group (Meier et al., 2018; Rhodes et al., 2010) . Also, the variety of alleles that we found in the CRISPR-Cas9 injected embryos suggests that they are very deleterious alleles ( Fig. 2A) , and it would very interesting to isolate them, and look for differences or redundancy in its phenotype in mutant strains for each of these alleles. So our data confirms that the CTCF function is required not only in the early stages of development, but it happens to be necessary through later stages as well.
The embryonic lethality that we found in the zebrafish, is also observed in the mouse (Fedoriw et al., 2004; Heath et al., 2008) , putting CTCF as a relevant factor for embryonic development of different groups of vertebrates. Further, CTCF could share some physiological, and also, some functional molecular aspects between species, as our rescue experiment show that the human CTCF is able to replace the zebrafish protein ( Fig. 5) .
According to the CTCF protein distribution described in the present study, the phenotype that we found can explain the reduced size of the embryo, morphological aberrations and several spots of dying tissue ( Figs. 2 and 4 ; Delgado-Olguín et al., 2011; Rhodes et al., 2010) . This effect is similar to what happens when CTCF is reduced specifically in the developing limb (Soshnikova et al., 2010) or the brain (Watson et al., 2014) of the mouse, where affects the size and morphology of the tissues, and markers of cell death are detected. On this basis, we suggest that CTCF might regulate cell survival in different tissues.
In contrast, some regulatory functions of CTCF can be diversified between species. We previously reported two mechanisms by which CTCF is a positive regulator of p53 in human cells. It acts as a barrier for the incorporation of repressive histone marks upstream of the p53 promoter (Soto-Reyes and Recillas-Targa, 2010). Also, the CTCF protein binds the Wrap53 RNA (an antisense transcript that originates from the p53 locus) to regulate the expression of p53. The RNA binding domain of the human CTCF was mapped to the zinc fingers 10-11 plus the Cterminal region of the protein (Saldaña-Meyer et al., 2014) . In the zebrafish, the zinc fingers 10-11 are conserved, but the C-terminal region is not (Pugacheva et al., 2006) . In contrast with this CTCF function as a positive regulator of p53 in human cells, Rhodes et al. (2010) found that CTCF might be a negative regulator of p53 in the zebrafish embryo. We found that p53 is upregulated in CTCF knockdown morpholino injected embryos at 24 hpf (Fig. 6 ), but its level is normal in these morpholino injected embryos at 12 hpf (not shown). We consider the possibility that the regulatory influence of CTCF on several genes has a strong consequence in the cell homeostasis in different tissues, which if it is altered, has an accumulative influence on p53 activation and cell death. One interesting possibility to explore is that the absence of CTCF in the p53 locus could induce an aberrant long-distance contact with gene activating consequences, as it has been demonstrated before in other contexts (Hnisz et al., 2016) .
As in the case of p53, we found that CTCF is also a negative regulator of bbc3/PUMA, another proapoptotic gene, in the zebrafish embryo (Fig. 6) . This regulation has been detected in carcinoma cell lines, where CTCF is required to establish the boundaries between active and inactive chromatin mark domains (Gomes and Espinosa, 2010) . Therefore, the lack of CTCF in the zebrafish embryo might affect the chromatin mark domains or the tri-dimensional organization of the genome, inducing the aberrant trans-or cis-activation of the p53 and PUMA genes, affecting the apoptosis signaling pathways.
An alternative to the direct regulation of CTCF on apoptosis control genes, the massive cell death in the morphants could be caused indirectly, by the combinatorial effect of the deregulation of some of the 187 genes that we detected before by a microarray assay (Delgado-Olguín et al., 2011) or the 269 genes that were detected by RNA-seq in a recent work (Meier et al., 2018) . Between these, Wnt11 and Myogenin were downregulated. These factors control several aspects of muscle development. Further, in accordance to the morphant and the mutant phenotypes, we do not discard the role of CTCF in non-myogenic Fig. 3 . Validation of the CTCF morpholinos. A. RT-PCR from control embryos injected with the vehicle (control) or the morpholino targeting a splice site (mo-sp). The same region was amplified from gDNA for comparison. The scheme represents the primers used and the region amplified. B. Western blot for CTCF from control embryos injected with the vehicle (control), the morpholino targeting the translation start site (mo-aug) or the morpholino targeting a splice site (mo-sp). The band intensity was quantified and normalized against tubulin, and the mo level was compared to control (mean ± STD, n = 5). Fig. 4 . Phenotype of the CTCF morphants. 1-cell to 2-cell embryos were injected with mo-aug or mo-sp. A range of phenotypes was found at 24 hpf, from wild type, mild and severe phenotypes. Different structures were affected: a. Forebrain, b. Midbrain, c. Hindbrain, d. Eye, e. Notochord f. Somites. The percentages and the median of embryos with a mild or severe phenotype are shown in the graph. The statistical difference is noted with an asterisk (n = 4 assays, p = 0.006 for mo-aug; n = 9 assays, p = 0.2609 for mo-sp; one-tailed unpaired t-tests). Fig. 5 . Rescue of the morphant phenotype by CTCF mRNA injection. Embryos were injected only with mo-aug (mo) or mo and either 50 pg or 100 pg of the human in vitro transcribed CTCF mRNA, and photographed at 24 hpf. The regions affected with the mo, and partially rescued with the CTCF mRNA are indicated: a. Forebrain, b. Midbrain, c. Hindbrain, d. Eye, e. Notochord, f. Somites. The percentage of lethal or wild type embryos, or embryos with the phenotype described in Fig. 4 , was graphed.
pathways. An intriguing possibility is the regulation of neurogenic pathways since the CTCF mRNA is clearly enriched in the brain (Pugacheva et al., 2006) . Also, we found a CTCF motif up-stream of the Nocth1a promoter (not shown). Notch1a is a factor relevant for both, neurogenesis and somitogenesis in the zebrafish (Gray et al., 2001) . This could explain the absence of somites and possibly the reduction of head and tail.
In conclusion, we showed that CTCF is present during all the stages of the zebrafish development, in every region of the embryo. The lack of this factor is lethal, and generates morphological alterations throughout all the length of the body pattern. The lethality correlates with deregulation of proapoptotic genes, and establishes a basis to study the function of this relevant chromatin factor, on genes necessary for the zebrafish development, with possible conserved features in other organisms.
Material and methods
Fish maintenance and crosses
Wild-type zebrafish (Danio rerio) embryos were obtained from natural crosses of the line TAB-WIK, that was generated from 20 pairmatings between the strains TAB-14 and WIK, both obtained from the Zebrafish International Resource Center (ZIRC). They were reared at 26-28°C, under a 14 h light/10 h dark cycle and a 6.8-7.2 pH. Feeding consisted on freshly hatched brine shrimp and commercial food flakes (TetraMin). Embryos were obtained from individual crosses for injection experiments, and from natural crosses for immunostaining. Staging was in accordance to Kimmel et al., 1995. 
Zebrafish-CTCF antibody generation
RNA from embryos was used to generate cDNA (Reverse Transcription System, Promega), according to Peterson and Freeman (2009) . The DNA fragment encoding amino acids 723-798 was amplified by PCR with the primers 5′-GAATTCCGGCTGCTGCCATTATCCAG GCT-3′ (forward) and 5′-AAGCTTTCACC GGTCCATCATGCTAAG-3′ (reverse), cloned into the pGEM-T Easy plasmid vector (Promega), then subcloned into the pET28b expression vector (EMD Millipore) using EcoRI and HindIII as restriction sites. The expression system used was E. coli BL21 (DE3) bacteria. An overnight culture of this system was inoculated at 100 ml of fresh medium and growth to exponential phase. At this point, 1 mM IPTG was added for induction, and incubation was allowed to proceed for 4 h at 37°C at 250 rpm. Cells were harvested and suspended in phosphate-buffered saline (PBS). Cell lysate was obtained by sonication wit 10 cycles of 25 s each. Cell debris was removed by centrifugation at 14000 rpm for 10 min. The supernatant was passed by a Ni-NTA resin (Qiagen). The column was washed 15 times with 10 volumes of PBS + 20 mM imidazole. The peptide was eluted with PBS + 200 mM imidazole. Rabbits were immunized with the peptide, and the antiserum was tested by Western blot against embryo protein extracts. The antibody was purified with the AminoLink Plus Immobilization Kit (Thermo Scientific).
Whole-mount immunostaining of embryos
Immunostaining protocol of embryos until the 75%-epiboly stage was performed as in Sun et al. (2008) . Embryos were fixed overnight with 4% paraformaldehyde in PBS. All washes were done with 0.1% Tween-20 in PBS (PBT). Chorion was removed manually using fine-tip tweezers. Methanol and PBT were used for graded dehydration and rehydration. Embryos were permeabilized with 0.5% Triton X-100 in PBT for 15 min. Blocking and antibody incubations were done with 1% BSA in PBT. We used our own anti-Ctcf as primary antibody (see above). The goat anti-rabbit Alexa Fluor 488 secondary antibody (Molecular Probes) was diluted 1:1000. Images were taken on an Olympus FV10 Confocal Microscope.
The chorion of embryos from the bud stage onwards was removed manually with fine-tip tweezers. The fixation was done on 4% paraformaldehyde in PBS overnight at 4°C. All washes were done with blocking solution (0.1% BSA, 1% Triton X-100 in PBS). For blocking, the embryos remained in blocking solution overnight at 4°C. Permeabilization was done with cold acetone, 10 min at −20°C. After washes, the embryos were incubated with the primary antibody at Fig. 6 . CTCF is required for the proper expression of proapoptotic genes. The expression levels of p53 and bbc3/PUMA were assayed by RT-PCR, from RNA of embryos in the 18-21somite stages, injected with the mo-aug. The morphants were classified according to whether they showed a phenotype (mild or severe) or no phenotype (wild type), as shown in Fig. 4 (mean ± STD; n = 4 assays).
blocking solution overnight, at 4°C. Washes were done, and the secondary antibody was diluted in blocking solution and incubated for 2 h at room temperature.
The autofluorescence signal in early embryos (less than the bud stage) was corrected with the Image Calculator in Fiji ImageJ (Schindelin et al., 2012) , as suggested for Billinton and Knight (2001) . The unspecific autofluorescence signal (obtained from the filter set for DAPI) was subtracted to the signal obtained from the filter set for the antibody fluorophore.
CRISPR-Cas9 genome editing assay
The assay was based on Gagnon et al. (2014) . The sgRNA against CTCF was designed using CHOPCHOP against the first coding exon of ctcf. The gene-specific oligonucleotide (with a SP6 promoter) has the sequence 5′-ATTTAGGTGACACTATA-GGGACC GACTGAGGCCGTGG-GTTTTAGAGCTA GAAATAGCAAG-3′ and the constant oligonucleotide has the sequence 5′-AAAAGCACCGACTCGGT GCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATT TCTAGCTCTAAAAC-3′. The MEGAscript SP6 kit (Ambion) was used for sgRNA transcription. To generate the Cas9 mRNA, the pCS2-Cas9 plasmid (Addgene) was transcribed with the mMESSAGE mMACHINE kit (Ambion). Each embryo was injected with 133 pg of gRNA and 200 pg of Cas9 mRNA diluted in Danieau (0.58 M NaCl, 7 mM KCl, 4 mM MgSO 4 , 6 mM Ca(NO 3 ) 2 , 50 mM HEPES). Pools of embryos at 24 hpf were used to extract DNA. The oligos 5′-CCAA CTTTACCTCAA TTGCACA-3′ (forward) and 5′-TTGGTATGTCTTGCACTCCTTG-3′ (reverse) were used to amplify the targeted region by PCR for T7 endonuclease I assay (NEB) and for cloning fragments for sequencing.
Morpholino oligonucleotide injection and rescue experiment
One morpholino targeting the transcription start site of ctcf (moaug) and one morpholino targeting the splicing site between exons 2 and 3 (mo-sp), already validated (Delgado-Olguín et al., 2011) were used. Embryos at one-to two-cell stages were injected with 4 ng of morpholino using a PV380 Pneumatic PicoPump (World Precision Instruments), and then reared in E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , 0.33 mM MgSO 4 , 0.1% methylene blue) at 28.5°C (Cold Spring Harbor Protoc., 2011). Phenotypes were photographed at 24 hpf with a Nikon SMZ1500 stereomicroscope, with an AxioCam MRc (Zeiss). For the rescue experiments, CTCF mRNA was transcribed in vitro with the mMESSAGE mMACHINE kit (Ambion), from the plasmid pCI-7.1 containing the full-length human CTCF cDNA (kindly provided by Elena Klenova, University of Essex, Essex, United Kingdom). Embryos were injected with a mix of 4 ng of mo-aug and either 50 or 100 pg of CTCF mRNA.
RT-qPCR
Total RNA from pools of 50-70 embryos at 90%-epiboly (to check the effect of the mo-sp morpholino) or at 24 hpf (for P53 and PUMA expression) was extracted according to Peterson and Freeman (2009) and used to generate cDNA (Reverse Transcription System, Promega). The primers targeting exons 2 and 3 of CTCF (to check the effect of the mo-sp) had the sequences: 5′-ACAGAAGTCATGGAGGCT GC-3′ (forward) and 5′-CTGTGTTGTAGCGCAGCTTG-3′ (reverse). The primer sequences for p53, β-actin and bbc3/PUMA are already reported (Rhodes et al., 2010; Toruno et al., 2014) . qRT PCRs were performed in a StepOne Real-Time PCR System (Applied Biosystems).
Protein extraction for Western blot
The protocol was based on Link et al. (2006) . Briefly, the chorion of embryos at 90%-epiboly stage was removed manually using fine-tip tweezers. They were transferred to a 1.5-ml tube with deyolking buffer (625 mM Tris-HCl pH 6.8, 1.8 mM KCl, 1.25 mM NaHCO 3 ). They were passed through a narrow tip by pipetting, to get the yolk sac disrupted, and mixed with a vortex. Embryos were centrifuged at 300g for 30 s and the supernatant was discarded. 0.5 μl/embryo of loading buffer (625 mM Tris-HCl pH 6.8, 50% glycerol, 15% SDS, 12.5% β-mercaptoethanol, bromophenol blue) was added, and the mix was boiled for 5 min. 5 μl of the protein sample were used in each SDS-PAGE run.
